2021
DOI: 10.1088/1361-6560/ac1d1e
|View full text |Cite
|
Sign up to set email alerts
|

Patient-specific microdosimetry: a proof of concept

Abstract: Microscopic energy deposition distributions from ionizing radiation vary depending on biological target size and are used to predict the biological effects of an irradiation. Ionizing radiation is thought to kill cells or inhibit the cell cycle mainly by damaging DNA in the cell nucleus. The size of cells and nuclei depends on tissue type, cell cycle, and malignancy, all of which vary between patients. The aim of this study was to develop methods to perform patient-specific microdosimetry, that being, determin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 37 publications
0
2
0
Order By: Relevance
“…For both voxel sizessimulated, we calculated microdosimetricspectra in 39 different spherical target sizessuch that predictionsof energydeposition probabilitiesin targetswhose sizes correspondto biologicaltargetsof interest can be made. One such implementation has been described in past work by DeCunha et al (2021aDeCunha et al ( , 2021b, which demonstratedthe feasibility of performingpatient-specific or tissue-specific microdosimetry (DeCunha et al 2021b(DeCunha et al , 2021a. By weighting a series of microdosimetric spectra in various target sizes accordingto a patient's known cell and nucleus-sizedistributions, a patient-specific microdosimetric distribution can be calculated.…”
Section: Target Size Weighting Of Microdosimetric Spectramentioning
confidence: 99%
“…For both voxel sizessimulated, we calculated microdosimetricspectra in 39 different spherical target sizessuch that predictionsof energydeposition probabilitiesin targetswhose sizes correspondto biologicaltargetsof interest can be made. One such implementation has been described in past work by DeCunha et al (2021aDeCunha et al ( , 2021b, which demonstratedthe feasibility of performingpatient-specific or tissue-specific microdosimetry (DeCunha et al 2021b(DeCunha et al , 2021a. By weighting a series of microdosimetric spectra in various target sizes accordingto a patient's known cell and nucleus-sizedistributions, a patient-specific microdosimetric distribution can be calculated.…”
Section: Target Size Weighting Of Microdosimetric Spectramentioning
confidence: 99%
“…The significance of microdosimetric investigations is demonstrated by its potential for supporting development of novel treatment modalities (e.g. nanotherapy involving gold nanoparticles (Zygmanski andSajo 2016, Sakata et al 2018)), and new understandings of radiobiological effects of radiation exposure (Pater et al 2016, DeCunha et al 2021, Bertolet et al 2021.…”
Section: Introductionmentioning
confidence: 99%
“…The significance of microdosimetric investigations is demonstrated by its potential for supporting development of novel treatment modalities (e.g., nanotherapy involving gold nanoparticles 23,133 ), and new understandings of radiobiological effects of radiation exposure. [134][135][136][137] Despite the importance of microdosimetry, analyses of microdosimetric distributions often rely on first-order statistics (e.g., mean and standard deviation) 19,20 with little-to-no consideration of the spatial distribution of data. Chapter 2 introduced Haralick texture analysis for the quantitative characterization of dosimetric distributions across micro-to macroscopic length scales, focusing on examples to illustrate proof-of-concept.…”
Section: Introductionmentioning
confidence: 99%